Skip to main content

BSACI-Symposium_2024-Slider-Web-Banner_2560px-x-600px_Final

Programme

The educational programme features sessions presented by each global society.

View live stream
TIME PROGRAMME
09:00 – 09:05 WELCOME
transparent09:05 – 10:30
WAO SESSION – IMMUNOTHERAPY
Chairs:

  • For WAO: Prof Bryan Martin, Ohio State University Columbus, USA
  • For BSACI: Dr George Gkimpas, Royal Preston Hospital, UK
09.05 – 09.20 Personalized medicine in immunotherapy

AIT is a paradigmatic example of Disease Modyfing Treatment and of Personalized Medicine. The Molecular Allergy Diagnosis (or Component Diagnosis or PAMD@) is a clear added value in defining the true sensitization in allergic patients and the possibility of shared decision with patients about SCIT.

Giorgio Walter Canonica, Humanitas Research Hospital, Italy

09.20 – 09.35 Immunotherapy and component testing: potential role in the future

The first premise for the prescription of immunotherapy based on PAMD@ is the assessment of IgE positivity to genuine versus cross-reactive allergens. Allergen immunotherapy should be prescribed to patients with demonstrated IgE-mediated sensitivity to relevant allergens that induce clinical manifestations.

Ignacio J. Ansotegui, Hospital Quironsalud Bizkaia, Spain

09.35 – 09.50 Oral Immunotherapy: A shared-decision discussion

Two clinicians will discuss 5 key questions most allergists and patients are asking about OIT. Practical advice on how to have an informative and effective shared-decision making conversation with a patient who is considering oral immunotherapy.

Dana Wallace, Nova Southeastern University College of Allopathic Medicine Fort Lauderdale, USA
John Oppenheimer, Clin professor of Medicine, UMDNJ-Rutgers, USA

09.50 – 10.05 Using immunotherapy to prevent the atopic march.
Mário Morais-Almeida, CUF – Hospitais e Clínicas, Portugal
10.05 – 10.30 Panel Q&A
10:30 – 10:45 BREAK
transparent

10:45 – 12:10

EACCI-logo-tran
EAACI UPDATE

Chairs:

  • For EAACI: Dr Maria Torres, University of Malaga and Malaga Regional University Hospital, Spain
  • For BSACI: Dr Mo Shamji, Imperial College, UK
10.45 – 11.00 New nomenclature on allergic diseases. From Bench to bedside

The cultural change brought by the new nomenclature will lead to novel concepts of diagnostic tools, improving therapies, and disease management and will guide future research into more innovative strategies for patient care.

Marek Jutel, Wroclaw Medical University, Poland

11.00 – 11.15 EAACI Guidelines on the diagnosis and management of IgE-mediated food allergy

This talk will provide clear and practical recommendations to be applied in clinical practice in order to improve the accuracy of food allergy diagnosis around the world.

Alexandra F. Santos, King’s College London, UK

11.15 – 11.30 Allergy to stings and bites from non-Hymenoptera insects: available diagnostics and treatment

Allergy to rare or locally important arthropods is not well known. The key is to be aware of rare arthropods and learn how to diagnose and treat allergy.

Gunter Sturm, Medical University of Graz, Austria

11.30 – 11.45 Severe asthma in real life. The EARL initiative

The EAACI EARL program is working on integrating Real-World evidence and EBM in health guidelines, since a defined method about how to integrate RWE in guidelines is still missing. Delegates will learn the value of RWE and the proposal to create guidelines on the correct methodology to handle data coming from randomized, non-randomized studies and from registries.

Stefano Del Giacco, University of Cagliari, Italy

11.45 – 12.10 Panel Q&A
12.10 – 12.40 BREAK
12.40 – 13.50 Presidents’ Forum
The presidents of the partner Societies will revisit the allergy state-of-the-art
Chair:

  • For BSACI: Dr Glenis Scadding, Royal National ENT Hospital and University College, UK

Speakers:
For BSACI: Prof Graham Roberts, University of Southampton, UK
For EAACI: Prof Stefano Del Giacco, University of Cagliari, Italy
For WAO: Prof Bryan Martin, Ohio State University Columbus, USA
For AAAAI: Prof Jonathan Bernstein, University of Cincinnati College of Medicine, Bernstein Allergy group and Bernstein Clinical Research Center, USA

13.50 – 14.10 BREAK
transparent
14:10 – 15.35
BSACI-logo-tran
BSACI SESSION – CHALLENGING INTERACTIVE CASES
Chairs:

  • Dr Shuaib Nasser, Cambridge University Hospitals NHS Foundation Trust, UK
  • Dr Matt Doyle, Jersey Allergy Clinic, Jersey, Channel Islands
14.10 – 14.25 Food allergy cases

Composite dishes often make it difficult to track down the allergen responsible for food allergic reactions. It is key to take a detailed history of exactly what was in the dish that provoked symptoms and undertake a food challenge if the history does not match the test results.

Isabel Skypala, Guys and St Thomas NHS Foundation Trust & Imperial College, UK

14.25 – 14.40 Perioperative allergy cases

Perioperative allergy is a rare but devasting event which can be uniquely challenging to recognise, investigate and diagnose. This session will cover some of the complexities and pitfalls in the end-to-end journey from initial event to eventual diagnosis.

Louise Savic, Leeds Teaching Hospitals NHS Trust, UK

14.40 – 14.55 Gastro Allergy cases

Multi-system allergic disease is increasing globally. Although many will be aware about the increases in allergy respiratory and dermatological presentations, gastro-intestinal conditions are also seeing a significant rise in prevalence.
  • Edward Gaynor, Great Ormond Street Hospital, UK
  • Leanne Goh, Imperial College Healthcare Trust and Great Ormond Street Hospital, UK
14.55 – 15.10 Immunodeficiency cases

This talk highlights presentation of interesting immunodeficiency cases, how they are diagnosed and how to manage these patients.

Ariharan Anantharachagan, Lancashire Teaching Hospitals NHS Foundation Trust, UK

15.10 – 15.35 Panel Q&A
15:35 – 15:50 BREAK
15:50 – 16:50 COMPANY SYMPOSIUM

DBV Technologies
Chairs:

  • Gideon Lack, KHP Institute of Women and Children’s Health at Evelina London, Guy’s & St. Thomas’ NHS Foundation Trust, London, UK
  • Hugh Sampson, Icahn School of Medicine at Mount Sinai, New York, USA

Epicutaneous immunotherapy for peanut allergy: from science to clinical practice

  • Gideon Lack, KHP Institute of Women and Children’s Health at Evelina London, Guy’s & St. Thomas’ NHS Foundation Trust, London, UK
  • Hugh Sampson, Icahn School of Medicine at Mount Sinai, New York, USA
  • Stefania Arasi, Bambino Gesù Children Research Hospital (IRCCS), Rome
transparent
16.50 – 18:15
AAAAI-logo-tran
AAAAI UPDATE
Chairs:

  • For AAAAI: Prof Jonathan Bernstein, University of Cincinnati College of Medicine, Bernstein Allergy group and Bernstein Clinical Research Center, USA
  • For BSACI: Prof Graham Roberts, University of Southampton, UK
16.50 – 17.05 The ACAAI/AAAAI Atopic Dermatitis guidelines

The Atopic Dermatitis Guidelines: 2023 AAAAI/ACAAI Joint Task Force (JTF) on Practice Parameters GRADE- and Institute of Medicine-based recommendations will assist clinicians in caring for their patients with atopic dermatitis.

Lynda Schneider, Harvard Medical School & Boston Children’s Hospital, USA

17.05 – 17.20 GRADE guidelines for chronic rhinosinusitis with nasal polyps

An update of the JTF chronic rhinosinusitis with NP guidelines which is a very common clinical presentation seen by Allergists and Immunologists. This is a GRADE document so the certainty of medical evidence supporting recommendations is provided. This talk could reaffirm or change the way clinicians are currently managing their patients with CRSwNP.

Jonathan Bernstein, University of Cincinnati College of Medicine, Bernstein Allergy group and Bernstein Clinical Research Center, USA

17.20 – 17.35 Asthma: What’s new in EPR4 and GINA.

Evidence based strategies for the management of asthma in all age groups are available to improve the care of children with asthma around the world.

Leonard Bacharier, Vanderbilt University Medical Center, USA

17.35 – 17.50 Drug Allergy: A Practise parameter update

The US Joint Task Force recently completed an update to the drug allergy practice parameters. This update was a data-derived and expert consensus document covering key areas of drug allergy. This session will aim to improve the global understanding of the US drug allergy practice parameter approaches to antibiotic allergy assessment and de-labeling.

Kimberly Blumenthal, Mass General Brigham, USA

17.50 – 18.15 Panel Q&A
18:15 – 18:20 CLOSING AND PRESIDENTS’ REMARKS